IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Record Date31-10-2023
31-10-2023
IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Conference Call for Q2 FY2431-10-2023
IPCA Pithampur unit in minimally acceptable state of compliance by US FDA
IPCA Labs will release its Q2 results on November 1031-10-2023
IPCA LABORATORIES LTD. - 524494 - Classification Of USFDA Inspection For Our Manufacturing Facility At SEZ Indore, Pithampur
Classification of USFDA Inspection for our manufacturing facility at SEZ Indore, Pithampur31-10-2023
IPCA LABORATORIES LTD. - 524494 - Revision In The Record Date For Entitlement Of Interim Dividend
Revision in the Record Date for entitlement of Interim Dividend26-10-2023
IPCA LABORATORIES LTD. - 524494 - Revision In Record Date For Entitlement Of Interim Dividend
Revision in record date for entitlement of Interim Dividend26-10-2023
IPCA LABORATORIES LTD. - 524494 - Record Date For Interim Dividend
Record Date for Interim Dividend26-10-2023
IPCA LABORATORIES LTD. - 524494 - Corporate Action-Board to consider Dividend
Record Date for Interim Dividend 2023-2425-10-2023
IPCA LABORATORIES LTD. - 524494 - Board Meeting Intimation for Standalone And Consolidated Unaudited Results For Q2 H1FY24 And Interim Dividend
IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve Standalone and Consolidated Unaudited Results for Q2 H1FY24 and Interim Dividend25-10-2023
Neutral IPCA Laboratories; target of Rs 860: Motilal Oswal
Motilal Oswal recommended Neutral rating on IPCA Laboratories with a target price of Rs 860 in its research report dated October 22, 2023.25-10-2023